Growth Metrics

Lexicon Pharmaceuticals (LXRX) Profit After Tax: 2009-2011

Historic Profit After Tax for Lexicon Pharmaceuticals (LXRX) over the last 3 years, with Dec 2011 value amounting to -$33.8 million.

  • Lexicon Pharmaceuticals' Profit After Tax fell 47.16% to -$33.8 million in Q4 2011 from the same period last year, while for Dec 2011 it was -$116.2 million, marking a year-over-year decrease of 14.19%. This contributed to the annual value of -$116.2 million for FY2011, which is 14.19% down from last year.
  • Per Lexicon Pharmaceuticals' latest filing, its Profit After Tax stood at -$33.8 million for Q4 2011, which was down 29.66% from -$26.1 million recorded in Q3 2011.
  • Lexicon Pharmaceuticals' 5-year Profit After Tax high stood at -$22.7 million for Q3 2009, and its period low was -$33.8 million during Q4 2011.
  • Over the past 3 years, Lexicon Pharmaceuticals' median Profit After Tax value was -$26.1 million (recorded in 2010), while the average stood at -$26.2 million.
  • Examining YoY changes over the last 5 years, Lexicon Pharmaceuticals' Profit After Tax showed a top increase of 5.12% in 2011 and a maximum decrease of 47.16% in 2011.
  • Lexicon Pharmaceuticals' Profit After Tax (Quarterly) stood at -$23.5 million in 2009, then rose by 2.31% to -$23.0 million in 2010, then crashed by 47.16% to -$33.8 million in 2011.
  • Its last three reported values are -$33.8 million in Q4 2011, -$26.1 million for Q3 2011, and -$26.6 million during Q2 2011.